Keysar SB, Gomes N, Miller B, Jackson BC, Le PN, Morton JJ, Reisinger J, Chimed TS, Gomez KE, Nieto C, Frederick B, Pronk GJ, Somerset HL, Tan AC, Wang XJ, Raben D, Su TT, Jimeno A. Targeting head and neck cancer stem cells by inhibiting translation elongation with SVC112. Cancer Res. 2020 Mar 1;80(5):1183-1198. PMID: 31911553.
Morton JJ, Jackson BC, Keysar SB, Reisinger J, Chimed TS, Le PN, Gomez KE, Nieto C, Miller B, Gao D, Tan AC, Somerset HL Medina T, Wang XJ, Robinson W, Roop D, Gonzalez R, Jimeno A. Studying patient immunotherapy resistance and tumor hyperprogression in an autologous humanized mouse xenograft melanoma model. Molecular Cancer Research. 2020 Oct. PMID: 33087417.
Jimeno A, Moore KN, Gordon M, Chugh R, Diamond JR, Aljumaily R, Mendelson D, Kapoun AM, Xu L, Stagg R, Smith DC. A first-in-human phase 1a study of the bispecific anti-DLL4/anti-VEGF antibody navicixizumab (OMP-305B83) in patients with previously treated solid tumors. Invest New Drugs. 2018 Sep 19. PMID: 30229512.
Le PN, Keysar SB, Miller B, Eagles JR, Chimed TS, Reisinger J, Gomez KE, Nieto C, Jackson BC, Somerset HL, Morton JJ, Wang XJ, Jimeno A. Wnt signaling dynamics in head and neck squamous cell cancer tumor-stroma interactions. Mol Carcinog. 2019 Mar;58(3):398-410. PMID: 30378175
Gomez K, Wu F, Keysar SB, Morton JJ, Miller B, Chimed TS, Le PN, Nieto C, Chowdhury FN, Tyagi A, LyonsTR, Young CD, Zhou H, Somerset HL, Wang XJ, Jimeno A. Cancer cell CD44 mediates macrophage/monocyte-driven regulation of head and neck cancer stem cells. Cancer Res 2020, CAN-20-1079 accepted 7/29/2020. 10.1158/0008-5472.